CNS Pharmaceuticals CNSP Stock
CNS Pharmaceuticals Price Chart
CNS Pharmaceuticals CNSP Financial and Trading Overview
| CNS Pharmaceuticals stock price | 0.24 USD |
| Previous Close | 2.18 USD |
| Open | 2.16 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 1000 |
| Day's Range | 2 - 2.18 USD |
| 52 Week Range | 0.61 - 11.31 USD |
| Volume | 314.6K USD |
| Avg. Volume | 3.67M USD |
| Market Cap | 8.95M USD |
| Beta (5Y Monthly) | 1.122796 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNSP Valuation Measures
| Enterprise Value | 4.21M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.18 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.3775511 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.247 |
Trading Information
CNS Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.122796 |
| 52-Week Change | -74.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.31 USD |
| 52 Week Low | 0.61 USD |
| 50-Day Moving Average | 1.74 USD |
| 200-Day Moving Average | 3.24 USD |
CNSP Share Statistics
| Avg. Volume (3 month) | 3.67M USD |
| Avg. Daily Volume (10-Days) | 1.32M USD |
| Shares Outstanding | 4.14M |
| Float | 3.83M |
| Short Ratio | 0.22 |
| % Held by Insiders | 14.23% |
| % Held by Institutions | 6.26% |
| Shares Short | 229.06K |
| Short % of Float | 5.62% |
| Short % of Shares Outstanding | 5.53% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -91.49% |
| Return on Equity (ttm) | -186.44% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -17034746 USD |
| Net Income Avi to Common (ttm) | -17054304 USD |
| Diluted EPS (ttm) | -12.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.11M USD |
| Total Cash Per Share (mrq) | 1.23 USD |
| Total Debt (mrq) | 289.08K USD |
| Total Debt/Equity (mrq) | 8.28 USD |
| Current Ratio (mrq) | 1.777 |
| Book Value Per Share (mrq) | 1.568 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12305208 USD |
| Levered Free Cash Flow (ttm) | -5894884 USD |
Profile of CNS Pharmaceuticals
| Country | United States |
| State | TX |
| City | Houston |
| Address | 2100 West Loop South |
| ZIP | 77027 |
| Phone | 800 946 9185 |
| Website | https://www.cnspharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Pomeranian Medical University, and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston, Texas.
Q&A For CNS Pharmaceuticals Stock
What is a current CNSP stock price?
CNS Pharmaceuticals CNSP stock price today per share is 0.24 USD.
How to purchase CNS Pharmaceuticals stock?
You can buy CNSP shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CNS Pharmaceuticals?
The stock symbol or ticker of CNS Pharmaceuticals is CNSP.
Which industry does the CNS Pharmaceuticals company belong to?
The CNS Pharmaceuticals industry is Biotechnology.
How many shares does CNS Pharmaceuticals have in circulation?
The max supply of CNS Pharmaceuticals shares is 10.63M.
What is CNS Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
CNS Pharmaceuticals PE Ratio is now.
What was CNS Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
CNS Pharmaceuticals EPS is -10 USD over the trailing 12 months.
Which sector does the CNS Pharmaceuticals company belong to?
The CNS Pharmaceuticals sector is Healthcare.
CNS Pharmaceuticals CNSP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}